featured
Risk of Major Bleeding, Stroke/Systemic Embolism, and Death Associated With Different Oral Anticoagulants in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of the American Heart Association
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Risk of Major Bleeding, Stroke/Systemic Embolism, and Death Associated With Different Oral Anticoagulants in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease
J Am Heart Assoc 2024 Aug 20;13(16)e034641, Y Xu, SH Ballew, AR Chang, LA Inker, ME Grams, JI ShinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.